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In 1954 Perry and Mount (1) described a
technic of measuring and recording the Gal-
vanic Skin Response (GSR) in normal human
subjects. Using this method other studies were
reported in which sweat inhibiting drugs were
consistently followed by an increase in skin resist-
ance or lowering of the GSR level, while sweat-
stimulating drugs appeared to decrease the
resistance or elevate the GSR level (2, 3, 4). These
results supported the theory that the GSR phe-
nomenon is directly correlated with sweat gland
function (5). Additional studies of the responses
of sympathectomized subjects and of the effects
of varying drug dosages have also supported this
hypothesis (6). Controlled experiments have
shown that these effects cannot be attributed to
the order of drug administration or adapta-
tion (7).
Following the establishment of the correlation
between the GSR and sweating in normal sub-
jects, studies were initiated in certain cutaneous
diseases in which abnormalities of the sweat
glands might be present. Acroscierosis was
selected because it is characterized by atrophic
changes in the epidermis, dermis and cutaneous
appendages. In this disease, the sweat glands
would be expected to have some functional im-
pairment. Therefore, two acrosclerosis patients
were selected for a preliminary evaluation of
their GSR reactions to sweat stimulating and
sweat inhibiting drugs.
MATERIALS AND METHODS
In a recent discussion of scleroderma, O'Leary
et al. (8) stated that "acrosclerosis typically
involves the hands, forearms, face, upper part of
the chest, and legs to a milder and slighter de-
gree. The vasospastic or Raynaud's phenomenon
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predominates, together with tightening of the
facies and other involved sites." The two sub-
jects in the present study were selected because
they fulfilled the above criteria. One, R. O'M.,
and the other, T. O'L. were respectively, 41 and
63 years of age. Both had intensive medical and
laboratory workups at the Veterans Administra-
tion Center, Wadsworth General Hospital in Los
Angeles, California. However, only pertinent find-
ings will be included in the present report. Each
subject began with Raynaud's phenomenon of
the hands with gradual and progressive extension
of the process to involve the face, forearms,
chest and feet. At the time of testing, these in-
volved areas were smooth, "tight" and atrophic.
Biopsy specimens, which were taken from the
dorsal surface of the hand in each subject, showed
essentially the same findings. There was hyper-
keratosis and atrophy of the epidermis. The
dermis showed some thinning, basophilic degener-
ation in the upper and middle thirds and homoge-
nization of the connective tissue. The adnexal
structures were absent except for the sweat glands
which showed atrophy, some degenerative
changes in the cells and dilatation of the ducts.
Mild perivascular lymphocytic infiltration was
present, but no obliterative changes were seen in
the blood vessels. These histologic changes are
considered to be characteristic of acroscierosis by
O'Leary et at. (8).
In the present experiments both subjects were
tested with three different substances including
Banthine bromide (5 mgm.), pilocarpine HCL
(5 mgm.) and a placebo (0.5 cc distilled water).
Each drug dose was dissolved in 0.5 cc of dis-
tilled water. In each individual experiment the
subject was placed in the circuit by means of a
pair of non-polarizing electrodes attached to the
hypothenar eminences of the palms and another
pair attached to the flexor surface of each fore-
arm distal to the elbow crease. Following the
intramuscular injection of the test substance, the
GSR level was recorded continuously for 45 min-
utes using the previously described technique
(1—4, 6, 7). By mechanically switching connec-
tions from one pair of electrodes to another on
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alternate ten second intervals, it was possible to
obtain separate GSR records for the forearms and
palms (6). All tests were conducted by the same
investigator, in the same room, in the morning,
1 hours after breakfast. There was an interval
of one to four days between successive tests.
R. O'M. was tested twice to the placebo, five
times to Banthine and twice to pilocarpine.
T. O'L. was tested three times to the placebo,
twice to Banthine and three times to pilocarpine. FIG. 2a
The results were essentially the same for each
test substance in both subjects. Therefore, a
representative set of records of T. O'L. have been
selected to demonstrate drug effects and the
results compared with those obtained with the
same substances in a normal control subject.
RESULTS
Figure 1A shows the result of the placebo injec-
tion in the control subject and Figure lB the
effect of the placebo in T. O'L. The forearm
records appear to be unchanged throughout the
experiment. The palm record in the control and FIG. 2b
T. O'L. demonstrates temporary fluctuations
which are not sustained.
Figure 2A shows a definite rise in the GSR
level in the forearm of the control beginning four
minutes after injection of pilocarpine. Figure 2B
shows a similar post-pilocarpine rise in the GSR
level of the forearm record of T. O'L. Eight
FIG. 3a
FIG. la
FIG. 3b
minutes after injection the GSR level of the fore•
arms crosses that of the palms. The latter remains
essentially unchanged as does the forearm record
of the control.
Fio. lb Figure 3A demonstrates a decrease in GSR
\ \-
-\.-- _\__\
AN OBSEItVATION IN ACROSCLEROSIS 175
level in the palms and forearms of the control
following Banthine. The same drug produces a
similar decrease in GSR level in the palms of
T. O'L., however, there is no apparent change in
his forearm record.
DISCUSSION
En the present experiments the GSR level has
been observed to either rise, fall or remain
unchanged. The changes may be either sustained
or temporary. The former effects can be observed
in Figures 2A, 2B, 3A and 3B following the
administration of pilocarpine or Banthine. Pre-
vious studies (6, 7) have correlated a sustained
rise in GSR level (decreased resistance) with
increased sweating. This is demonstrated in
Figures 2A and 2B from pilocarpine. A sustained
fall in GSR level as seen in Figures 3A and 3B
is associated with decreased sweating (6, 7). The
observations in the present experiments, there-
fore, coincide for the most part with what would
be anticipated from past experiments. The tem-
porary changes as seen in Figures 1A and lB are
associated with extraneous stimuli such as noises
or talking. However, their effect is transient and
they tend to occur about a general level. They
are not sustained as seen in the pilocarpine and
Banthine records. The forearm records of the
placebo tests remain flat and unaltered through-
out the experiment. This apparent difference in
reactivity between the forearm and palm has
been observed in other experiments, but the
reason for the difference is not known.
Pilocarpine produced a sustained rise in GSR
level in the forearms of both the control and
acroscierosis patient. However, neither showed
the same change in their palm record. The fore-
arm record of T. O'L. also did not demonstrate
an anticipated decrease in GSR level after Ban-
thine. These non-responsive areas have been
encountered in previous experiments. This is
probably a function of the dosage because in
other experiments (9) larger dosages of either
pilocarpine or Banthine have usually been fol-
lowed by the appropriate change in GSR level.
The present findings are of interest because
they suggest that histopathological findings may
not always indicate the functional capacity of the
skin and its appendages. Biopsy studies of the
involved areas in two acrosclerosis patients
showed atrophic changes in the sweat glands and
their ducts. Consequently, impairment of their
function would be anticipated. This should have
been demonstrated by a lack of GSR response to
a sweat stimulating and sweat inhibiting drug.
The results, however, did not fulfill these ex-
pectations. Both the control and acrosclerosis
patients had similar effects on their GSR levels
from pilocarpine and Banthine. A probable
explanation would be that sufficient numbers of
sweat glands were still functioning adequately to
permit normal drug effects on the GSR level.
It is certainly conceivable that acroselerosis
could progress to such a degree that sweat glands
might be destroyed so that non-reactive GSR
levels might result. This is suggested by Wagner's
observation that patients with congenitally
absent sweat glands have a low GSR level which
does not react to sweat stimulating or sweat
inhibiting drugs (10). The present observations
suggest further studies in acroscierosis and sclero-
derma using the described technic.
SUMMARY
Two patients with acrosclerosis were tested
with a sweat stimulating and sweat inhibiting
drug and their galvanic skin response was found
to be similar to a control. This would indicate
that they had normal sweat gland function de-
spite the atrophic changes seen in their biopsy
studies. These observations suggest that histo-
pathologic findings are not always an accurate
indication of the functional state of sweat glands.
Further studies in this and related diseases are
indicated to determine whether the present
findings are common or not.
CONCLUSIONS
A normal galvanic skin response to Banthine,
pilocarpine and placebo was observed in two
patients with acrosclerosis.
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